6RPT image
Deposition Date 2019-05-14
Release Date 2020-01-08
Last Version Date 2024-11-13
Entry Detail
PDB ID:
6RPT
Title:
Structure of tick complement inhibitor CirpT1 complexed with macroglobubulin domain 4 of human complement C5
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.70 Å
R-Value Free:
0.27
R-Value Work:
0.22
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Complement C5
Gene (Uniprot):C5
Chain IDs:A (auth: E), C (auth: A), E (auth: C)
Chain Length:133
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Putative 8.9 kDa family member
Chain IDs:B (auth: F), D (auth: B), F (auth: D)
Chain Length:113
Number of Molecules:3
Biological Source:Rhipicephalus pulchellus
Ligand Molecules
Primary Citation
An inhibitor of complement C5 provides structural insights into activation.
Proc.Natl.Acad.Sci.USA 117 362 370 (2020)
PMID: 31871188 DOI: 10.1073/pnas.1909973116

Abstact

The complement system is a crucial part of innate immune defenses against invading pathogens. The blood-meal of the tick Rhipicephalus pulchellus lasts for days, and the tick must therefore rely on inhibitors to counter complement activation. We have identified a class of inhibitors from tick saliva, the CirpT family, and generated detailed structural data revealing their mechanism of action. We show direct binding of a CirpT to complement C5 and have determined the structure of the C5-CirpT complex by cryoelectron microscopy. This reveals an interaction with the peripheral macro globulin domain 4 (C5_MG4) of C5. To achieve higher resolution detail, the structure of the C5_MG4-CirpT complex was solved by X-ray crystallography (at 2.7 Å). We thus present the fold of the CirpT protein family, and provide detailed mechanistic insights into its inhibitory function. Analysis of the binding interface reveals a mechanism of C5 inhibition, and provides information to expand our biological understanding of the activation of C5, and thus the terminal complement pathway.

Legend

Protein

Chemical

Disease

Primary Citation of related structures